2026-06-29T09:37:12Zhttps://docta.ucm.es/rest/oai/request

oai:docta.ucm.es:20.500.14352/1153562025-01-22T00:49:17Zcom_20.500.14352_14col_20.500.14352_15

00925njm 22002777a 4500 dc Roscales García, Silvia author Ortega, Andrea author Martín-Aragón Álvarez, Sagrario author Bermejo Bescos, María De La Paloma author García Csaky, Aurelio author 2012 The development of the regioselective conjugate addition of boronic acids to ketoglutaconic esters under transition metal catalysis is reported. Among the different catalysts tested for this transformation, the dicationic PdII catalysts generated with Pd(OCOCF3)2, dppben, and HBF4 performed best in terms of yields, regioselectivities and avoidance of Heck-type by-products. The resulting 4-aryl-2-oxopentadienoates were transformed into pyridazin-3(2H)-ones, potentially useful for the therapy of neurodegenerative diseases. These compounds simultaneously exhibited β-secretase activity, inhibition of β-amyloid (βA) aggregation, and disaggregation of pre-formed βA fibrils, and also had a good scavenging profile for intracellular reactive oxygen species (ROS). 10.1002/ejoc.201200734 https://hdl.handle.net/20.500.14352/115356 https://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/ejoc.201200734 Pd(II)-catalyzed conjugate addition of boronic acids to ketoglutaconic esters toward the synthesis of functionalized pridazin-3(2H)-ones with neuroprotective activity